These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24211635)

  • 1. Indole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells.
    Sallam AA; Ayoub NM; Foudah AI; Gissendanner CR; Meyer SA; El Sayed KA
    Eur J Med Chem; 2013; 70():594-606. PubMed ID: 24211635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic.
    Goda AA; Siddique AB; Mohyeldin M; Ayoub NM; El Sayed KA
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29751615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioguided discovery and pharmacophore modeling of the mycotoxic indole diterpene alkaloids penitrems as breast cancer proliferation, migration, and invasion inhibitors.
    Sallam AA; Houssen WE; Gissendanner CR; Orabi KY; Foudah AI; El Sayed KA
    Medchemcomm; 2013 Oct; 4(10):. PubMed ID: 24273638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1S,2E,4S,7E,11E)-2,7,11-Cembratriene-4,6-diol semisynthetic analogs as novel c-Met inhibitors for the control of c-Met-dependent breast malignancies.
    Ebrahim HY; Mohyeldin MM; Hailat MM; El Sayed KA
    Bioorg Med Chem; 2016 Nov; 24(22):5748-5761. PubMed ID: 27681240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
    Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
    Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
    Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
    Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
    Zhang Y
    Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
    Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and biological evaluation of fused tetrahydroisoquinoline derivatives as Wnt/β-catenin signaling inhibitors to suppress colorectal cancer.
    Zhou J; Xu B; Shen Q; Zhang Z; Hu Y; Wang M; Su Y; Lei Z; Zhang W; Liu T; Liu H; Hu T; Zhou Y
    Eur J Med Chem; 2024 Oct; 276():116664. PubMed ID: 39018921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semisynthetic analogues of the marine cembranoid sarcophine as prostate and breast cancer migration inhibitors.
    Hassan HM; Sallam AA; Mohammed R; Hifnawy MS; Youssef DT; El Sayed KA
    Bioorg Med Chem; 2011 Aug; 19(16):4928-34. PubMed ID: 21775154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21.
    Zhang Y; Tian S; Xiong J; Zhou Y; Song H; Liu C
    Chem Res Toxicol; 2018 May; 31(5):302-307. PubMed ID: 29600711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo.
    Xue M; Wang Q; Zhao J; Dong L; Ge Y; Hou L; Liu Y; Zheng Z
    J Nutr Biochem; 2014 Feb; 25(2):104-10. PubMed ID: 24290517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 3-arylethynyl-substituted pyrido[2,3,-b]pyrazine derivatives and pharmacophore model as Wnt2/β-catenin pathway inhibitors in non-small-cell lung cancer cell lines.
    Gong YD; Dong MS; Lee SB; Kim N; Bae MS; Kang NS
    Bioorg Med Chem; 2011 Sep; 19(18):5639-47. PubMed ID: 21855350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
    Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.